180 related articles for article (PubMed ID: 22355271)
1. Genome-wide DNA methylation profiling of cell-free serum DNA in esophageal adenocarcinoma and Barrett esophagus.
Zhai R; Zhao Y; Su L; Cassidy L; Liu G; Christiani DC
Neoplasia; 2012 Jan; 14(1):29-33. PubMed ID: 22355271
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide methylation analysis shows similar patterns in Barrett's esophagus and esophageal adenocarcinoma.
Xu E; Gu J; Hawk ET; Wang KK; Lai M; Huang M; Ajani J; Wu X
Carcinogenesis; 2013 Dec; 34(12):2750-6. PubMed ID: 23996928
[TBL] [Abstract][Full Text] [Related]
3. MiRNA-Related SNPs and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus: Post Genome-Wide Association Analysis in the BEACON Consortium.
Buas MF; Onstad L; Levine DM; Risch HA; Chow WH; Liu G; Fitzgerald RC; Bernstein L; Ye W; Bird NC; Romero Y; Casson AG; Corley DA; Shaheen NJ; Wu AH; Gammon MD; Reid BJ; Hardie LJ; Peters U; Whiteman DC; Vaughan TL
PLoS One; 2015; 10(6):e0128617. PubMed ID: 26039359
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA expression profiles of esophageal cancer.
Feber A; Xi L; Luketich JD; Pennathur A; Landreneau RJ; Wu M; Swanson SJ; Godfrey TE; Litle VR
J Thorac Cardiovasc Surg; 2008 Feb; 135(2):255-60; discussion 260. PubMed ID: 18242245
[TBL] [Abstract][Full Text] [Related]
5. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA
Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175
[TBL] [Abstract][Full Text] [Related]
6. Identification of loci of functional relevance to Barrett's esophagus and esophageal adenocarcinoma: Cross-referencing of expression quantitative trait loci data from disease-relevant tissues with genetic association data.
Schröder J; Schüller V; May A; Gerges C; Anders M; Becker J; Hess T; Kreuser N; Thieme R; Ludwig KU; Noder T; Venerito M; Veits L; Schmidt T; Fuchs C; Izbicki JR; Hölscher AH; Dakkak D; Jansen-Winkeln B; Moulla Y; Lyros O; Niebisch S; Mehdorn M; Lang H; Lorenz D; Schumacher B; Mayershofer R; Vashist Y; Ott K; Vieth M; Weismüller J; Mangold E; Nöthen MM; Moebus S; Knapp M; Neuhaus H; Rösch T; Ell C; Gockel I; Schumacher J; Böhmer AC
PLoS One; 2019; 14(12):e0227072. PubMed ID: 31891614
[TBL] [Abstract][Full Text] [Related]
7. Whole Genome Methylation Analysis of Nondysplastic Barrett Esophagus that Progresses to Invasive Cancer.
Dilworth MP; Nieto T; Stockton JD; Whalley CM; Tee L; James JD; Noble F; Underwood TJ; Hallissey MT; Hejmadi R; Trudgill N; Tucker O; Beggs AD
Ann Surg; 2019 Mar; 269(3):479-485. PubMed ID: 29384778
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma.
Yang H; Gu J; Wang KK; Zhang W; Xing J; Chen Z; Ajani JA; Wu X
Clin Cancer Res; 2009 Sep; 15(18):5744-52. PubMed ID: 19737949
[TBL] [Abstract][Full Text] [Related]
9. Serum Glycoprotein Biomarker Discovery and Qualification Pipeline Reveals Novel Diagnostic Biomarker Candidates for Esophageal Adenocarcinoma.
Shah AK; Cao KA; Choi E; Chen D; Gautier B; Nancarrow D; Whiteman DC; Saunders NA; Barbour AP; Joshi V; Hill MM
Mol Cell Proteomics; 2015 Nov; 14(11):3023-39. PubMed ID: 26404905
[TBL] [Abstract][Full Text] [Related]
10. Impact of Tissue Enolase 1 Protein Overexpression in Esophageal Cancer Progression.
Hoang AT; Vizio B; Chiusa L; Cimino A; Solerio D; Do NH; Pileci S; Camandona M; Bellone G
Int J Med Sci; 2021; 18(6):1406-1414. PubMed ID: 33628097
[TBL] [Abstract][Full Text] [Related]
11. Whole-miRNome profiling identifies prognostic serum miRNAs in esophageal adenocarcinoma: the influence of Helicobacter pylori infection status.
Zhai R; Wei Y; Su L; Liu G; Kulke MH; Wain JC; Christiani DC
Carcinogenesis; 2015 Jan; 36(1):87-93. PubMed ID: 25381453
[TBL] [Abstract][Full Text] [Related]
12. Role of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma.
Agarwal A; Polineni R; Hussein Z; Vigoda I; Bhagat TD; Bhattacharyya S; Maitra A; Verma A
Int J Clin Exp Pathol; 2012; 5(5):382-96. PubMed ID: 22808291
[TBL] [Abstract][Full Text] [Related]
13. Subtypes of Barrett's oesophagus and oesophageal adenocarcinoma based on genome-wide methylation analysis.
Yu M; Maden SK; Stachler M; Kaz AM; Ayers J; Guo Y; Carter KT; Willbanks A; Heinzerling TJ; O'Leary RM; Xu X; Bass A; Chandar AK; Chak A; Elliott R; Willis JE; Markowitz SD; Grady WM
Gut; 2019 Mar; 68(3):389-399. PubMed ID: 29884612
[TBL] [Abstract][Full Text] [Related]
14. A multigene expression panel for the molecular diagnosis of Barrett's esophagus and Barrett's adenocarcinoma of the esophagus.
Brabender J; Marjoram P; Salonga D; Metzger R; Schneider PM; Park JM; Schneider S; Hölscher AH; Yin J; Meltzer SJ; Danenberg KD; Danenberg PV; Lord RV
Oncogene; 2004 Jun; 23(27):4780-8. PubMed ID: 15107828
[TBL] [Abstract][Full Text] [Related]
15. Pleiotropic analysis of cancer risk loci on esophageal adenocarcinoma risk.
Lee E; Stram DO; Ek WE; Onstad LE; MacGregor S; Gharahkhani P; Ye W; Lagergren J; Shaheen NJ; Murray LJ; Hardie LJ; Gammon MD; Chow WH; Risch HA; Corley DA; Levine DM; Whiteman DC; Bernstein L; Bird NC; Vaughan TL; Wu AH
Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1801-3. PubMed ID: 26364162
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling of esophageal cancer: comparative analysis of Barrett's esophagus, adenocarcinoma, and squamous cell carcinoma.
Greenawalt DM; Duong C; Smyth GK; Ciavarella ML; Thompson NJ; Tiang T; Murray WK; Thomas RJ; Phillips WA
Int J Cancer; 2007 May; 120(9):1914-21. PubMed ID: 17236199
[TBL] [Abstract][Full Text] [Related]
17. A comparative analysis by SAGE of gene expression profiles of esophageal adenocarcinoma and esophageal squamous cell carcinoma.
van Baal JW; Milana F; Rygiel AM; Sondermeijer CM; Spek CA; Bergman JJ; Peppelenbosch MP; Krishnadath KK
Cell Oncol; 2008; 30(1):63-75. PubMed ID: 18219111
[TBL] [Abstract][Full Text] [Related]
18. Identification of a key role of widespread epigenetic drift in Barrett's esophagus and esophageal adenocarcinoma.
Luebeck EG; Curtius K; Hazelton WD; Maden S; Yu M; Thota PN; Patil DT; Chak A; Willis JE; Grady WM
Clin Epigenetics; 2017; 9():113. PubMed ID: 29046735
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-196a is a potential marker of progression during Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in esophagus.
Maru DM; Singh RR; Hannah C; Albarracin CT; Li YX; Abraham R; Romans AM; Yao H; Luthra MG; Anandasabapathy S; Swisher SG; Hofstetter WL; Rashid A; Luthra R
Am J Pathol; 2009 May; 174(5):1940-8. PubMed ID: 19342367
[TBL] [Abstract][Full Text] [Related]
20. Shared Genetic Etiology of Obesity-Related Traits and Barrett's Esophagus/Adenocarcinoma: Insights from Genome-Wide Association Studies.
Böhmer AC; Hecker J; Schröder J; Gharahkhani P; May A; Gerges C; Anders M; Becker J; Hess T; Kreuser N; Thieme R; Noder T; Venerito M; Veits L; Schmidt T; Fuchs C; Izbicki JR; Hölscher AH; Dietrich A; Moulla Y; Lyros O; Lang H; Lorenz D; Schumacher B; Mayershofer R; Vashist Y; Ott K; Vieth M; Weismüller J; Moebus S; Knapp M; Neuhaus H; Rösch T; Ell C; Nöthen MM; Whiteman DC; Tomlinson I; Jankowski J; Fitzgerald RC; Palles C; Vaughan TL; Gockel I; Thrift AP; Fier H; Schumacher J
Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):427-433. PubMed ID: 31748258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
